These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34191153)

  • 1. 18F-NaF PET/CT imaging of bone formation induced by bioactive glass S53P4 after mastoid obliteration.
    Timmermans AJ; Quak JJ; Hagen PJ; Colnot DR
    Eur J Hybrid Imaging; 2019 Oct; 3(1):18. PubMed ID: 34191153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioactive glass obliteration of the mastoid significantly improves surgical outcome in non-cholesteatomatous chronic otitis media patients.
    Vos J; de Vey Mestdagh P; Colnot D; Borggreven P; Orelio C; Quak J
    Eur Arch Otorhinolaryngol; 2017 Dec; 274(12):4121-4126. PubMed ID: 28956143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioactive glass S53P4 in mastoid obliteration surgery for chronic otitis media and cerebrospinal fluid leakage.
    Sarin J; Grénman R; Aitasalo K; Pulkkinen J
    Ann Otol Rhinol Laryngol; 2012 Sep; 121(9):563-9. PubMed ID: 23012893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioactive glass (S53P4) as obliteration material in subtotal petrosectomy: initial experience.
    Lindeboom JJ; Colnot DR; Buwalda J
    J Laryngol Otol; 2023 Jan; 137(1):105-107. PubMed ID: 35535475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioactive glass granules for mastoid and epitympanic surgical obliteration: CT and MRI appearance.
    Bernardeschi D; Law-Ye B; Bielle F; Hochet B; Sterkers O; Dormont D; Pyatigorskaya N
    Eur Radiol; 2019 Oct; 29(10):5617-5626. PubMed ID: 30888487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implantation of the Bonebridge BCI 602 after Mastoid Obliteration with S53P4 Bioactive Glass: A Safe Method of Treating Difficult Anatomical Conditions-Preliminary Results.
    Król B; Cywka KB; Skarżyńska MB; Skarżyński PH
    Life (Basel); 2021 Apr; 11(5):. PubMed ID: 33921929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerance and safety of 45S5 bioactive glass used in obliteration procedures during middle ear surgery: Preliminary results.
    Al Tamami N; Bawazeer N; Fieux M; Zaouche S; Tringali S
    Am J Otolaryngol; 2020; 41(6):102542. PubMed ID: 32620365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioactive glass S53P4 in the filling of cavities in the mastoid cell area in surgery for chronic otitis media.
    Stoor P; Pulkkinen J; Grénman R
    Ann Otol Rhinol Laryngol; 2010 Jun; 119(6):377-82. PubMed ID: 20583735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mastoid obliteration and external auditory canal reconstruction using 3D printed bioactive glass S53P4 /polycaprolactone scaffold loaded with bone morphogenetic protein-2: A simulation clinical study in rabbits.
    Yu F; Fan X; Wu H; Ou Y; Zhao X; Chen T; Qian Y; Kang H
    Regen Ther; 2022 Dec; 21():469-476. PubMed ID: 36313396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mastoid obliteration with S53P4 bioactive glass in cholesteatoma surgery.
    de Veij Mestdagh PD; Colnot DR; Borggreven PA; Orelio CC; Quak JJ
    Acta Otolaryngol; 2017 Jul; 137(7):690-694. PubMed ID: 28125327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous and Labyrinthine Tolerance of Bioactive Glass S53P4 in Mastoid and Epitympanic Obliteration Surgery: Prospective Clinical Study.
    Bernardeschi D; Nguyen Y; Russo FY; Mosnier I; Ferrary E; Sterkers O
    Biomed Res Int; 2015; 2015():242319. PubMed ID: 26504792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mastoid Obliteration with S53P4 Bioactive Glass Can Make Bonebridge Implantation Feasible: A Case Report.
    Król B; Porowski M; Cywka KB; Skarżyńska MB; Skarżyński PH
    Am J Case Rep; 2020 Nov; 21():e925914. PubMed ID: 33168798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotics in mastoid and epitympanic obliteration with S53P4 bioactive glass: A retrospective study.
    Alciato L; Bernardeschi D; Pourcher V; Mkrtchyan N; Tankéré F; Sterkers O; Lahlou G
    Laryngoscope Investig Otolaryngol; 2022 Oct; 7(5):1584-1594. PubMed ID: 36258865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Multicenter Retrospective Case Review of Outcomes and Complications of S53P4 Bioactive Glass.
    G Leonard C; McNally S; Adams M; Hampton S; McNaboe E; E Reddy CE; A Bailie N
    J Int Adv Otol; 2021 May; 17(3):234-238. PubMed ID: 34100748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Applications of S53P4 Bioactive Glass in Bone Healing and Osteomyelitic Treatment: A Literature Review.
    van Gestel NA; Geurts J; Hulsen DJ; van Rietbergen B; Hofmann S; Arts JJ
    Biomed Res Int; 2015; 2015():684826. PubMed ID: 26504821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mastoidectomy cavity obliteration with bioactive glass: a pilot study.
    Silvola JT
    Otolaryngol Head Neck Surg; 2012 Jul; 147(1):119-26. PubMed ID: 22371341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of bioactive glass for mastoid obliteration: a guinea pig model.
    Jang CH; Cho YB; Bae CS
    In Vivo; 2007; 21(4):651-5. PubMed ID: 17708361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Use of Bioactive Glass S53P4 as Bone Graft Substitute in the Treatment of Chronic Osteomyelitis and Infected Non-Unions - a Retrospective Study of 50 Patients.
    Malat TA; Glombitza M; Dahmen J; Hax PM; Steinhausen E
    Z Orthop Unfall; 2018 Apr; 156(2):152-159. PubMed ID: 29665602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilisation of bioactive glass S53P4 inside an induced membrane for severe bone defect with high risk of infection: a multi-center preliminary experience.
    Aurégan JC; Villain B; Glombitza M; Blokhuis T; Heinänen M; Bégué T
    Injury; 2022 Oct; 53 Suppl 2():S13-S19. PubMed ID: 35871084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.